news

Three more US states announce lawsuits against Purdue

14
SHARES

A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.

A total of 48 US states are accusing Purdue Pharma of helping to contribute to an opioid health crisis in the US. The narcotic OxyContin is a prescription drug which helps to relieve pain in adults.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

California, Hawaii and Maine are the newest states to file lawsuits against the pharmaceutical company. The allegations charge the pharmaceutical company of understating the risks of addiction to the drug while exaggerating the advantages. There are currently more than 72,000 deaths from overdosing a year in the US with 49,000 of them caused by opioids. The accusers claim this number has been heightened by OxyContin.

The Sackler family, who own the company, have also been sued by individual states. Nebraska and Michigan remain the only two states who have not sued the company.

The prosecutors claim that the marketing of the treatment allowed doctors to prescribe higher doses of OxyContin than necessary. 

“Purdue’s deliberate and deceptive marketing and sale of these drugs sacrificed the wellbeing of Californians for billions of dollars in profits and fuelled an unprecedented national public health crisis,” said California’s attorney general, Xavier Becerra. 

Purdue have defended themselves, saying the allegations are “not supported by facts and are fundamentally flawed.”

Approximately 1,600 cases have been filed against Purdue Pharma and other opioid manufacturers are being consolidated and transferred to a judge in Ohio.

If the number of lawsuits continues to rise, then the company may be forced to file for bankruptcy.

Related organisations

Related drugs

Related people

Share via
Share via